VolitionRX Ltd (VNRX)

Jul 19, 2025

Is VolitionRx Limited a good long term investmentSky-high profits - jammulinksnews.com

Jul 19, 2025

Jul 18, 2025

What drives VolitionRx Limited stock pricePowerful profit generation - jammulinksnews.com

Jul 18, 2025

Jul 16, 2025

Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation - MarketScreener

Jul 16, 2025

Jul 15, 2025

What makes VolitionRx Limited stock price move sharplyProven Win Setups - Newser

Jul 15, 2025

Jul 15, 2025

How VolitionRx Limited stock performs during market volatilityShort Term Risk Controlled Alerts - Newser

Jul 15, 2025

Jul 15, 2025

Why VolitionRx Limited stock attracts strong analyst attentionDefensive Stock Picks with Upside - Newser

Jul 15, 2025

Jul 08, 2025

VolitionRx Limited Announces Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - MarketScreener

Jul 08, 2025

Jul 08, 2025

Breakthrough: New 5-Minute Blood Test Could Transform Emergency Care and Sepsis Detection - Stock Titan

Jul 08, 2025

Jul 08, 2025

Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - Ariva

Jul 08, 2025

Jul 02, 2025

VolitionRx:Nu.Q advances in lung cancer management - Research Tree

Jul 02, 2025

Jun 27, 2025

VNRX INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of VolitionRx Ltd. (NYSE: VNRX) and Encourages Long-Term Investors to Contact the Firm - ACCESS Newswire

Jun 27, 2025

Jun 16, 2025

VolitionRx CEO Cameron Reynolds acquires $7,372 in common stock By Investing.com - Investing.com India

Jun 16, 2025

Jun 16, 2025

VolitionRx CEO Cameron Reynolds acquires $7,372 in common stock - Investing.com

Jun 16, 2025

Jun 12, 2025

Volition Announces MARS Consortium Clinical Study Suggests Nu.Q H3.1 Concentrations Are Closely Associated With Sepsis And Organ Failure - MarketScreener

Jun 12, 2025

Jun 11, 2025

VolitionRx (NYSE:VNRX) Rating Increased to Strong-Buy at Jones Trading - Defense World

Jun 11, 2025

Jun 10, 2025

VolitionRX (VNRX) Coverage Initiated with a 'Buy' Rating by Jones Trading | VNRX Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

JonesTrading Initiates Coverage on VolitionRx Limited With Buy Rating, $3 Price Target - marketscreener.com

Jun 10, 2025

Jun 10, 2025

Jones Trading initiates VolitionRX with Buy, sets $3 target - Investing.com India

Jun 10, 2025

Jun 09, 2025

Jones Trading initiates VolitionRX with Buy, sets $3 target By Investing.com - Investing.com UK

Jun 09, 2025

Jun 09, 2025

VolitionRx (VNRX) Receives Buy Rating with Promising Price Targe - GuruFocus

Jun 09, 2025

Jun 09, 2025

VolitionRx initiated with a Buy at JonesResearch - TipRanks

Jun 09, 2025

Jun 09, 2025

VolitionRx (VNRX) Receives Buy Rating with Promising Price Target | VNRX Stock News - GuruFocus

Jun 09, 2025

Jun 04, 2025

Director Makes Bold Move with Major VolitionRX Stock Purchase - TipRanks

Jun 04, 2025

Jun 04, 2025

Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties - Yahoo Finance

Jun 04, 2025

Jun 04, 2025

VolitionRx director Guy Innes buys $10,772 in common stock By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 04, 2025

VolitionRx director Guy Innes buys $10,772 in common stock - Investing.com

Jun 04, 2025

May 27, 2025

VNRX: Management's key financial goal for 2025 is to be cash neutral on a full year basis. - Research Tree

May 27, 2025

May 27, 2025

VNRX: Management’s key financial goal for 2025 is to be cash neutral on a full year basis. Four operational milestones have been achieved thus far in 2025. Primary operational goal is to enter into multiple licensing agreements for human diagnostic applicati - Yahoo Finance

May 27, 2025

May 20, 2025

VolitionRx Limited (AMEX:VNRX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 20, 2025

May 19, 2025

VolitionRX Ltd. Earnings Call Reveals Promising Growth - TipRanks

May 19, 2025

May 19, 2025

VolitionRX shares hold as Benchmark maintains rating - Investing.com Australia

May 19, 2025

May 19, 2025

VNRX stock touches 52-week low at $0.42 amid market challenges - Investing.com Canada

May 19, 2025

May 19, 2025

VolitionRX shares hold as Benchmark maintains rating By Investing.com - Investing.com India

May 19, 2025

May 19, 2025

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats - Yahoo Finance

May 19, 2025

May 19, 2025

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats By Investing.com - Investing.com Canada

May 19, 2025

May 17, 2025

VolitionRX Ltd (VNRX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Milestones - Yahoo Finance

May 17, 2025

May 17, 2025

VolitionRx Reports Strong Q1 2025 Performance - TipRanks

May 17, 2025

May 16, 2025

VolitionRX (VNRX) Sees Revenue Growth and Cost Reduction in Q1 2 - GuruFocus

May 16, 2025

May 16, 2025

Earnings call transcript: VolitionRx misses Q1 2025 earnings forecast By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

Transcript : VolitionRx Limited, Q1 2025 Earnings Call, May 16, 2025 - marketscreener.com

May 16, 2025

May 16, 2025

Earnings call transcript: VolitionRx misses Q1 2025 earnings forecast - Investing.com

May 16, 2025

May 16, 2025

Volitionrx Ltd earnings missed by $0.02, revenue fell short of estimates - Investing.com UK

May 16, 2025

May 16, 2025

VolitionRX: Q1 Earnings Snapshot - CT Insider

May 16, 2025

May 16, 2025

VolitionRx Q1 2025 Earnings Call Transcript - MarketBeat

May 16, 2025

May 15, 2025

Volitionrx Ltd earnings missed by $0.03, revenue fell short of estimates - Investing.com South Africa

May 15, 2025

May 15, 2025

VolitionRx reports Q1 revenue $0.25M, consensus $1.08M - TipRanks

May 15, 2025

May 15, 2025

Volition (VNRX) Targets Diagnostic Market Expansion with Nu.Q Platform | VNRX Stock News - GuruFocus

May 15, 2025

May 15, 2025

VolitionRX Ltd Reports Q1 2025 Revenue of $0.25 Million, Missing - GuruFocus

May 15, 2025

May 15, 2025

VolitionRX Ltd (VNRX) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus

May 15, 2025